CN102199196B - 一种基因工程抗菌肽及其制备方法和应用 - Google Patents
一种基因工程抗菌肽及其制备方法和应用 Download PDFInfo
- Publication number
- CN102199196B CN102199196B CN2010102713147A CN201010271314A CN102199196B CN 102199196 B CN102199196 B CN 102199196B CN 2010102713147 A CN2010102713147 A CN 2010102713147A CN 201010271314 A CN201010271314 A CN 201010271314A CN 102199196 B CN102199196 B CN 102199196B
- Authority
- CN
- China
- Prior art keywords
- antibacterial peptide
- preparation
- antibacterial
- peptide
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 18
- 230000004151 fermentation Effects 0.000 claims abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 9
- 108060003100 Magainin Proteins 0.000 claims abstract description 6
- 108020004705 Codon Proteins 0.000 claims abstract description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 20
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 18
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 230000003115 biocidal effect Effects 0.000 claims description 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 238000010353 genetic engineering Methods 0.000 claims description 13
- 241000235648 Pichia Species 0.000 claims description 12
- 108010084455 Zeocin Proteins 0.000 claims description 12
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 101800003223 Cecropin-A Proteins 0.000 claims description 9
- HCQPHKMLKXOJSR-IRCPFGJUSA-N cecropin-a Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C1=CC=CC=C1 HCQPHKMLKXOJSR-IRCPFGJUSA-N 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 238000013461 design Methods 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 238000005215 recombination Methods 0.000 claims description 8
- 230000006798 recombination Effects 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- 238000011156 evaluation Methods 0.000 claims description 6
- 239000002054 inoculum Substances 0.000 claims description 6
- 239000013612 plasmid Substances 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 108091008146 restriction endonucleases Proteins 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108010042407 Endonucleases Proteins 0.000 claims description 3
- 102000004533 Endonucleases Human genes 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 101150031623 aox gene Proteins 0.000 claims description 3
- 238000002306 biochemical method Methods 0.000 claims description 3
- 238000007664 blowing Methods 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 230000005611 electricity Effects 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 238000001471 micro-filtration Methods 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000011027 product recovery Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 abstract description 7
- 244000144972 livestock Species 0.000 abstract description 5
- 241000235058 Komagataella pastoris Species 0.000 abstract 2
- 239000003674 animal food additive Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 108010036176 Melitten Proteins 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 241000276427 Poecilia reticulata Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 101500009721 Xenopus laevis Magainin-2 Proteins 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- MGIUUAHJVPPFEV-ABXDCCGRSA-N magainin ii Chemical compound C([C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 MGIUUAHJVPPFEV-ABXDCCGRSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102713147A CN102199196B (zh) | 2010-09-03 | 2010-09-03 | 一种基因工程抗菌肽及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102713147A CN102199196B (zh) | 2010-09-03 | 2010-09-03 | 一种基因工程抗菌肽及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102199196A CN102199196A (zh) | 2011-09-28 |
CN102199196B true CN102199196B (zh) | 2013-05-01 |
Family
ID=44660212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102713147A Active CN102199196B (zh) | 2010-09-03 | 2010-09-03 | 一种基因工程抗菌肽及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102199196B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108018223A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/MiAMP1 |
CN108018221A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ace-AMP1 |
CN108018222A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ac-AMP2 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102504019B (zh) * | 2011-12-01 | 2014-04-23 | 北京龙科方舟生物工程技术有限公司 | 一种分离天蚕素抗菌肽的方法 |
CN102907583B (zh) * | 2012-10-27 | 2018-06-15 | 北京大北农科技集团股份有限公司 | 猪β防御素2喷干粉,饲料添加剂,预混料及配合料 |
CN103352046A (zh) * | 2013-05-23 | 2013-10-16 | 甘肃智信达生物科技有限公司 | Apidaecin型抗菌肽在毕赤酵母菌中的表达及扩大培养 |
CN104357452A (zh) * | 2014-11-06 | 2015-02-18 | 南京林业大学 | 一种美国白蛾天蚕素a基因及其表达蛋白和应用 |
CN104447976B (zh) * | 2014-12-13 | 2017-10-10 | 安徽浩翔农牧有限公司 | 一种猪源抗菌肽cecropin P1突变体及其制备方法和应用 |
CN105968214A (zh) * | 2016-06-21 | 2016-09-28 | 中国农业大学 | 抗菌抗病毒杂合多肽及其制备方法与应用 |
CN107216375A (zh) * | 2017-06-01 | 2017-09-29 | 浙江万里学院 | 一种用于化妆品防腐剂的水母抗菌肽及其制备方法 |
CN107188943A (zh) * | 2017-06-01 | 2017-09-22 | 浙江万里学院 | 一种用于试剂盒防腐剂的泥蚶抗菌肽及其制备方法 |
CN107188942A (zh) * | 2017-06-01 | 2017-09-22 | 浙江万里学院 | 一种用于水产养殖饲料添加剂的花蛤抗菌肽及其制备方法 |
CN112662698A (zh) * | 2017-06-08 | 2021-04-16 | 中国农业科学院饲料研究所 | 新型抗菌肽dlp4的制备方法 |
CN108251478A (zh) * | 2018-02-08 | 2018-07-06 | 金华市铁骑士生物科技有限公司 | 一种从酵母菌发酵液中提取抗菌肽的方法 |
CN111100870A (zh) * | 2019-12-05 | 2020-05-05 | 广东容大生物股份有限公司 | 一种制备含有抗菌肽基因的酵母的方法 |
CN111349176B (zh) * | 2020-02-17 | 2022-04-19 | 浙江工商大学 | 一种细菌素pzj5杂合肽c-p1及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1896107A (zh) * | 2006-06-13 | 2007-01-17 | 南京农业大学 | 类天蚕素a-马盖宁杂合基因工程抗菌肽 |
-
2010
- 2010-09-03 CN CN2010102713147A patent/CN102199196B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1896107A (zh) * | 2006-06-13 | 2007-01-17 | 南京农业大学 | 类天蚕素a-马盖宁杂合基因工程抗菌肽 |
Non-Patent Citations (3)
Title |
---|
六种天蚕素类基因工程抗菌肽的研制及应用;王秀青;《中国博士学位论文全文数据库农业科技辑》;20080515(第5期);摘要,正文第25页第11行-第27页第8行,第31页第12行-第32页第14行,75页 * |
王秀青.六种天蚕素类基因工程抗菌肽的研制及应用.《中国博士学位论文全文数据库农业科技辑》.2008,(第5期),摘要,正文第25页第11行-第27页第8行,第31页第12行-第32页第14行,75页. |
黄志峰.杂合抗菌肽基因MA-E的改建及用一步蛋白纯化克隆系统表达.《中国优秀博硕士学位论文全文数据库(硕士)基础科学辑》.2002,(第1期),摘要及正文第8-11页. * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108018223A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/MiAMP1 |
CN108018221A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ace-AMP1 |
CN108018222A (zh) * | 2017-12-07 | 2018-05-11 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ac-AMP2 |
CN108018223B (zh) * | 2017-12-07 | 2020-12-29 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/MiAMP1 |
CN108018222B (zh) * | 2017-12-07 | 2020-12-29 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ac-AMP2 |
CN108018221B (zh) * | 2017-12-07 | 2020-12-29 | 浙江大学 | 用于抑制梨果实采后青霉病的制剂GS115/Ace-AMP1 |
Also Published As
Publication number | Publication date |
---|---|
CN102199196A (zh) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102199196B (zh) | 一种基因工程抗菌肽及其制备方法和应用 | |
CN105061603B (zh) | 抗菌肽-溶菌酶融合蛋白的制备方法及其应用 | |
CN101817883B (zh) | 一种家蝇天蚕素-人溶菌酶融合蛋白及其制备方法和应用 | |
CN101450964B (zh) | 一种基因工程抗菌肽及其制备方法与应用 | |
CN104341497B (zh) | 一种新型猪源抗菌肽突变体及其制备方法和应用 | |
CN104524564A (zh) | 一种鲫鱼疱疹病毒病复合疫苗制剂及制备方法和应用 | |
CN104630259A (zh) | 利用毕赤酵母表达人溶菌酶-抗菌肽Parasin I融合蛋白的方法 | |
CN102190718B (zh) | 重组对虾蛋白sf-p9及制备方法和应用 | |
CN104593388A (zh) | 一种鲫鱼疱疹病毒病jdorf25疫苗及制备方法和应用 | |
CN103621795A (zh) | 一种杂合抗菌肽作为饲料添加剂的应用 | |
CN104356222B (zh) | 一种猪源抗菌肽pr‑39突变体及其制备方法和应用 | |
CN101775068A (zh) | 新的天然抗菌肽、其编码序列及用途 | |
CN101864372A (zh) | 一种抗菌肽基因工程菌株的制备方法 | |
CN102093998B (zh) | 一种抗菌肽天蚕素饲料添加剂的制备方法 | |
CN104447976B (zh) | 一种猪源抗菌肽cecropin P1突变体及其制备方法和应用 | |
CN104789625A (zh) | 人α防御素5在酿酒酵母中分泌表达的方法 | |
CN104988170A (zh) | 一种融合抗菌肽及其制备方法和应用 | |
CN102079778B (zh) | 一种抗菌蛋白及其制备方法和应用 | |
CN104448006B (zh) | 一种杂合抗菌肽ce-pr及其应用 | |
CN1904036B (zh) | 基因工程菌混合培养生产三种人α防御素的方法 | |
CN101525629A (zh) | 人α防御素5活性肽的基因工程制备方法 | |
CN102080079B (zh) | 新型抗菌肽Misgurin突变体的制备方法与应用 | |
CN101323644A (zh) | 重组cecA-mil杂合基因抗菌肽 | |
CN105732792A (zh) | 一种酵母表达的鸡Cathelicidin1抗菌肽及其制备方法与应用 | |
CN105671069B (zh) | 一种蜜蜂肽表达载体及其构建方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Applicant after: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Co-applicant after: QINGDAO BOITE BIOPHARMACEUTICAL Co.,Ltd. Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Applicant before: Qingdao Vland Biotech INC. Co-applicant before: QINGDAO BOITE BIOPHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: QINGDAO CONTINENT BIOTECH CO., LTD. TO: QINGDAO KDN PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: QINGDAO WEILAN BIOLOGY CO., LTD. Free format text: FORMER NAME: QINGDAO KDN PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Patentee after: QINGDAO VLAND BIOTECH Inc. Patentee after: QINGDAO BOITE BIOPHARMACEUTICAL Co.,Ltd. Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Patentee before: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Patentee before: QINGDAO BOITE BIOPHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Patentee after: QINGDAO VLAND BIOTECH Inc. Patentee after: QINGDAO VLAND BIOTECH GROUP CO.,LTD. Address before: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Patentee before: QINGDAO VLAND BIOTECH Inc. Patentee before: QINGDAO BOITE BIOPHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 266061 north head of Shuangyuan Road, Qingda Industrial Park, Chengyang District, Qingdao City, Shandong Province Patentee after: QINGDAO VLAND BIOTECH Inc. Patentee after: Qingdao Blue Animal Health Group Co.,Ltd. Address before: 266061 north head of Shuangyuan Road, Qingda Industrial Park, Chengyang District, Qingdao City, Shandong Province Patentee before: QINGDAO VLAND BIOTECH Inc. Patentee before: QINGDAO VLAND BIOTECH GROUP CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |